Completed PHASE2 INTERVENTIONAL 2-arm NCT01718964

Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel) (Ghost-Basel)

Acute Effects of Cortisol on Heroin Craving in Opioid Dependence

Sponsor: Prof. Dominique de Quervain, MD

Updated 5 times since 2017 Last updated: Oct 29, 2013 Started: Nov 30, 2012 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Opioid Dependence and is currently completed. Prof. Dominique de Quervain, MD leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Prof. Dominique de Quervain, MD

Data source: University of Basel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland